We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

84 hedge funds and large institutions have $87.5M invested in VanEck Biotech ETF in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

335% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $436K

29% more capital invested

Capital invested by funds: $67.8M → $87.5M (+$19.6M)

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

3.9% more ownership

Funds ownership: 16.34% → 20.24% (+3.9%)

1% more funds holding

Funds holding: 83 → 84 (+1)

46% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 24

Holders
84
Holders Change
+1
Holders Change %
+1.2%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
24
Closed
8
Calls
$1.9M
Puts
$436K
Net Calls
+$1.46M
Net Calls Change
+$1.59M

Top Buyers

Rank Fund Capital Flow
1
CWM
Cornerstone Wealth Management
Missouri
+$8.99M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.5M
3
VF
Virtu Financial
New York
+$3.59M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.36M
5
Jane Street
Jane Street
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$830K
2
ClearBridge Investments
ClearBridge Investments
New York
-$540K
3
OAM
Occidental Asset Management
California
-$432K
4
TRCT
Tower Research Capital (TRC)
New York
-$422K
5
MCM
Murphy Capital Management
New Jersey
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
Janney Montgomery Scott
26
Janney Montgomery Scott
Pennsylvania
$816K – – –
ACA
27
Atlas Capital Advisors
Wyoming
$810K – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$789K – – –
SBH
29
Segall Bryant & Hamill
Illinois
$713K – – –
TC
30
Telemus Capital
Michigan
$674K – – –
Wells Fargo
31
Wells Fargo
California
$654K -$130K -1,000 -17%
TRCT
32
Tower Research Capital (TRC)
New York
$607K -$422K -3,248 -42%
SC
33
Scotia Capital
Ontario, Canada
$575K +$6.5K +50 +1%
CWM
34
Cornerstone Wealth Management
Missouri
$511K +$8.99M +69,149 New
Citadel Advisors
35
Citadel Advisors
Florida
$506K +$483K +3,711 New
IAMOG
36
Investors Asset Management of Georgia
Georgia
$503K – – –
WJA
37
Williams Jones & Associates
New York
$482K -$130K -1,000 -22%
IA
38
IFP Advisors
Florida
$463K -$366K -2,812 -45%
ClearBridge Investments
39
ClearBridge Investments
New York
$388K -$540K -4,150 -59%
AB
40
Atlas Brown
Kentucky
$378K -$3.25K -25 -0.9%
SB
41
Suntrust Banks
Georgia
$358K -$17.3K -133 -5%
MML Investors Services
42
MML Investors Services
Massachusetts
$345K +$330K +2,535 New
BPC
43
Banque Pictet & Cie
Switzerland
$341K – – –
Cambridge Investment Research Advisors
44
Cambridge Investment Research Advisors
Iowa
$311K -$10.8K -83 -4%
First Manhattan
45
First Manhattan
New York
$292K -$111K -850 -28%
PA
46
PFG Advisors
Arizona
$279K +$1.3K +10 +0.4%
TCM
47
Tufton Capital Management
Maryland
$251K – – –
B
48
Bailard
California
$249K – – –
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
$231K -$13.1K -101 -6%
MWA
50
MFA Wealth Advisors
Pennsylvania
$215K – – –
1
2
3 4

BBH Hedge Fund Activity: Q3 2018 in Review

84 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2018, worth a combined $87.5M — up 29% from $67.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BBH positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 24 trimmed.

The largest buyer was Cornerstone Wealth Management, opening a new position worth an estimated $8.99M. The largest seller was UBS Group, cutting an estimated $830K.

  • 84 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2018, up from 83 in Q2 2018.
  • Funds reported $87.5M of VanEck Biotech ETF stock for Q3 2018, up 29% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q3 2018 and 8 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2018 was Cornerstone Wealth Management, an estimated $8.99M added.
  • The largest VanEck Biotech ETF seller in Q3 2018 was UBS Group, an estimated $830K sold.

Based on aggregated 13F filings for Q3 2018.